Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

15.92USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$15.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
177,155
52-wk High
$34.98
52-wk Low
$15.16

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Hoyoung Huh

48 2012 Chairman of the Board

Sean McCarthy

51 President, Chief Executive Officer, Director

Debanjan Ray

40 2018 Chief Financial Officer and Head of Corporate Development

W. Michael Kavanaugh

61 2015 Chief Scientific Officer and Head - Research and Non-Clinical Development

Rachel Humphrey

56 2015 Chief Medical Officer